Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis
Sponsor: UMC Utrecht
Summary
The MANUS Trial aims to examine the safety, feasibility and potential efficacy of intramuscularly injected allogeneic mesenchymal stromal cells as treatment for digital ulcers of systemic sclerosis.
Official title: Mesenchymal Stromal Cells for Angiogenesis and Neovascularisation in Digital Ulcers of Systemic Sclerosis: the MANUS Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-10-06
Completion Date
2026-11-01
Last Updated
2025-09-10
Healthy Volunteers
No
Conditions
Interventions
Mesenchymal stromal cells
8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon).
Placebo
8 intramuscular injections at designated sites in the hand/forearm muscles of the most affected side. Blinded syringes will be used. Injections will be administered by an experienced clinician (plastic surgeon or hand surgeon).
Locations (1)
Universitair Medisch Centrum Utrecht
Utrecht, Netherlands